11 research outputs found

    Loop corrections for Kaluza-Klein AdS amplitudes

    Get PDF
    Recently we conjectured the four-point amplitude of graviton multiplets in AdS5×S5{\rm AdS}_5 \times {\rm S}^5 at one loop by exploiting the operator product expansion of N=4\mathcal{N}=4 super Yang-Mills theory. Here we give the first extension of those results to include Kaluza-Klein modes, obtaining the amplitude for two graviton multiplets and two states of the first KK mode. Our method again relies on resolving the large N degeneracy among a family of long double-trace operators, for which we obtain explicit formulas for the leading anomalous dimensions. Having constructed the one-loop amplitude we are able to obtain a formula for the one-loop corrections to the anomalous dimensions of all twist five double-trace operators.Comment: 37 pages. One ancillary file containing data on the correlator

    Pedigrees of cases carrying the R214C and G153D mutations.

    No full text
    <p>(A) R214C: African-American proband diagnosed with stage IIA, ER/PR positive, Her2/Neu positive, infiltrating ductal carcinoma of the breast at age 42 years. (B) G153D: Non-Hispanic Caucasian proband diagnosed with breast cancer at age 60 years and with stage IV, serous carcinoma of the ovary at age 79 years.</p

    Immunoblots of <i>RAD51C</i> in the yeast strains used for the two-hybrid analysis

    No full text
    <p>. The <i>upper panel</i> shows the immunoblot blot analysis of the yeast strains containing human XRCC3 and RAD51C while the <i>lower panel</i> shows the same immunoblots from the yeast strains used in the RAD51B and RAD51C analysis. The RAD51C-Gal4 fusion peptides were identified using an anti-Gal4 monoclonal antibody. The same lysates were probed with an antibody against β-actin as a control for equal loading of protein.</p

    Effect of <i>RAD51C</i> point mutations on the interaction with XRCC3 and RAD51B.

    No full text
    <p>(A) Yeast two-hybrid assays were performed with XRCC3 in the DNA-binding domain vector and either wild-type or site-specifically mutated <i>RAD51C</i> in the activating domain vector. (B) Yeast two-hybrid assays were performed with RAD51B in the DNA-binding domain vector and the <i>RAD51C</i> variants in the activating domain vector. Results from liquid ONPG assays are the average of 5–7 different transformants performed in triplicate, with the standard error of the mean. * : <i>P</i><0.05 and ** :<i>P</i>≤0.001 using the student <i>T</i>-test.</p

    Age-adjusted baseline characteristics among 727 postmenopausal women in the California Teachers Study diagnosed with lung cancer stratified by history of menopausal hormone therapy (MHT) use.

    No full text
    1<p>Race/ethnicity analysis was not adjusted for by age.</p>2<p>Other category for race/ethnicity includes: African American, Hispanic, Native American, Asian/Pacific Islander, Mixed and Unknown.</p>3<p>Mean pack-years calculated only among ever smoking women.</p

    Adjusted<sup>1</sup> hazard ratios (HR) and 95% confidence intervals (CI) for the association between menopausal hormone therapy (MHT) use and mortality among 727 postmenopausal women diagnosed with lung cancer following enrollment in the California Teachers Study.

    No full text
    1<p>Cox proportional hazards regression models using age (in days) as the time metric and stratified by age (in years) with the adjustment for race, a variable combining smoking status and pack-years (never smoker, former light smoker, former heavy smoker, current light smoker, current heavy smoker) and stage.</p><p>**All variables measured at baseline.</p
    corecore